Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Charcot-Marie-Tooth - Demyelinating Neuropathy Panel PreventionGenetics United States | 34 | 24 |
|
Invitae Charcot-Marie Tooth Disease Comprehensive Panel Invitae United States | 123 | 52 |
|
Charcot-Marie-Tooth Panel, Comprehensive CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 85 | 30 |
|
CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 95 | 62 |
|
Charcot-Marie-Tooth disease: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 67 | 54 |
|
Charcot-Marie-Tooth Hereditary Neuropathy NGS Panel Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center United States | 76 | 54 |
|
Paroxysmal Extreme Pain Disorder NGS Panel Fulgent Genetics United States | 185 | 53 |
|
Charcot-Marie-Tooth Disease Type 4 , Panel Massive Sequencing (NGS) 11 Genes Reference Laboratory Genetics Spain | 11 | 11 |
|
Motor Neuron Disorder and Related Diseases , Panel Massive Sequencing (NGS) 49 Genes Reference Laboratory Genetics Spain | 60 | 49 |
|
Charcot-Marie-Tooth Disease, Panel Massive Sequencing (NGS) 32 Genes Reference Laboratory Genetics Spain | 41 | 32 |
|
Hereditary Peripheral Neuropathy , Panel Massive Sequencing (NGS) 31 Genes Reference Laboratory Genetics Spain | 41 | 31 |
|
Optic Atrophy & Early Glaucoma NGS Panel Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center United States | 40 | 34 |
|
CHARCOT-MARIE-TOOTH DISEASE TYPE 4B2 Laboratorio de Genetica Clinica SL Spain | 1 | 1 |
|
Charcot-Marie-Tooth Disease Type 4 , Deletions-Duplications (MLPA) GDAP1,MTMR2,SBF2,PRX,SH3TC2 Genes Reference Laboratory Genetics Spain | 5 | 5 |
|
Charcot-Marie-Tooth Disease Type 4B2 , Sequencing SBF2 Gene Reference Laboratory Genetics Spain | 1 | 1 |
|
Asper Biogene Asper Biogene LLC Estonia | 19 | 20 |
|
CMT Advanced Evaluation - Nonprevalent Demyelinating Athena Diagnostics Inc United States | 17 | 14 |
|
CMT Advanced Evaluation - Nonprevalent Athena Diagnostics Inc United States | 25 | 21 |
|
GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases Spain | 37 | 34 |
|
GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases Spain | 34 | 32 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.